Loading clinical trials...

Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography | Clinical Trials | Clareo Health

COMPLETEDNANCT04505657

Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography

our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography

Lead sponsor: Aswan University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWNNA

Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion

NCT04505943 · IUCD Complication

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 29, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment150

Start dateSep 2020

Last updatedSep 29, 2021

Condition

IUCD Complication

Locations shown

Aswan University Hospital

Aswān

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 29, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions